Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
4516:TYO
Nippon Shinyaku Co Ltd
¥4,119.00
-2.18%
(-92.00) 1D
May 26, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4516...
Open
¥4,186
High
¥4,209
Low
¥4,089
Mkt. cap
289.37B
Avg. vol.
238.70K
Volume
201.50K
Dividend
3.01%
Quarterly dividend
¥31
Ex-dividend date
Mar 30, 2026
P/E ratio
9.33
52-wk high
¥6,529
52-wk low
¥2,967
EPS
¥441
Shares outstanding
67.35M
No. of employees
2K
News stories
From sources across the web
Profile
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that develops, manufactures, and markets prescription drugs and functional foods. Founded in 1911, the company initially focused on herbal medicines before expanding into modern pharmaceuticals, with current therapeutic areas including urology, hematology, intractable and rare diseases, and gynecology. Nippon Shinyaku is listed on the Tokyo Stock Exchange and has developed treatments such as viltolarsen for Duchenne muscular dystrophy. Wikipedia
About Nippon Shinyaku Co Ltd
CEO-
Employees2.24K
FoundedOct 1, 1919
Headquarters-
SectorPharmaceutical industry
Websitenippon-shinyaku.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
39.55B
40.10B
47.49B
43.64B
Cost of goods sold
12.66B
12.68B
16.68B
15.45B
Cost of revenue
12.66B
12.68B
16.68B
15.45B
Research and development expenses
6.19B
8.45B
8.40B
13.68B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.00B
10.36B
11.35B
11.86B
Operating expense
16.81B
17.92B
18.06B
25.02B
Total operating expenses
29.46B
30.60B
34.73B
40.47B
Operating income
10.08B
9.50B
12.75B
3.16B
Other non operating income
-2.00M
1.00M
-2.00M
1.00M
EBT including unusual items
10.50B
9.53B
13.20B
3.24B
EBT excluding unusual items
10.50B
9.53B
13.20B
3.24B
Income tax expense
2.25B
2.02B
3.11B
-642.00M
Effective tax rate
21.40%
21.19%
23.57%
-19.83%
Other operating expenses
625.00M
-888.00M
-1.68B
-518.00M
Net income
8.26B
7.50B
10.08B
3.88B
Net profit margin
20.87%
18.72%
21.23%
8.88%
Earnings per share
-
-
-
-
Interest and investment income
468.00M
82.00M
464.00M
118.00M
Interest expense
-46.00M
-55.00M
-19.00M
-46.00M
Net interest expenses
422.00M
27.00M
445.00M
72.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
11.67B
11.14B
14.41B
4.90B
Gain or loss from assets sale
-
19.00M
56.00M
56.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer